Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Version 13 adds the Contacts/Locations and Study Status sections to the record history. The update corresponds to Revision: v3.3.4 (2026-01-07).
    Difference
    0.6%
    Check dated 2026-01-14T02:04:44.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a footer note 'Revision: v3.3.3'. Removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' note from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T20:44:11.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The history now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0, reflecting minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:29:02.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removal of a government funding/operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T06:49:38.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new version entry has been added to the record history, reflecting an updated Study Status and related fields (e.g., Sponsor/Collaborators, Oversight).
    Difference
    0.1%
    Check dated 2025-11-03T20:36:24.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page changes remove the old recruitment status and date (Recruiting, 2024-11-21) and replace them with an updated recruitment status (Active, not recruiting) and updated date stamps (2025-10-16 and 2025-10-14) along with expanded section headers. Interpreting this, the study is currently active but not recruiting participants, and there are new or reorganized sections for study headers and contacts.
    Difference
    4%
    Check dated 2025-10-20T12:57:25.000Z thumbnail image

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.